# A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.

> **NCT01659762** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 16 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** autologous mesenchymal stromal cell

## Key facts

- **NCT ID:** NCT01659762
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-07
- **Final completion:** —
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01659762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01659762, "A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01659762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*